Kristin Yarema - Chief Commercial Officer at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Issuer Symbol
ATRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Yarema since 05 Mar 2025

Holdings reported by Kristin Yarema for Atara Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 171,415 $66,680 $0.3890 01 Mar 2022 Direct
Employee Stock Option (Right to Buy) 85,592 01 Mar 2022 Direct Common Stock

Transactions reported by Kristin Yarema for Atara Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.